首页> 外文期刊>Diagnostic microbiology and infectious disease >Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods.
【24h】

Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods.

机译:头孢托仑对近1000种非耐细菌分离物的活性以及体外药敏试验方法的发展。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Cefditoren (formerly ME-1206) is an investigational, orally administered cephalosporin ester with bactericidal activity against many Gram-positive and -negative organisms. Cefditoren potency against nearly 1000 non-fastidious species was determined by National Committee for Clinical Laboratory Standards (NCCLS) reference broth microdilution and standardized disk diffusion methods. Against staphylococci, usable cefditoren activity was completely correlated with oxacillin with respect to potency and susceptibility interpretation (mec A-negative strains). Cefditoren was very active against Klebsiella spp., Proteus mirabilis, Salmonella spp., and Escherichia coli (MIC(90) range, 0.12-1 microg/ml; median zone, 23-26 mm). Cefditoren had more limited activity against Citrobacter spp., Enterobacter spp., Serratia marcescens, and indole-positive Proteae (MIC(50) range, 0.12-1 microg/ml; MIC(90), > 16 microg/ml; median zone, 18-25 mm). Against Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Acinetobacter spp., and other non-fermentors, cefditoren was inactive (MIC(90), > 16 microg/ml; zone, 6 mm). Pharmacokinetic analysis of cefditoren showed that utilized dosages produce a plasma concentration that exceeds 0.5 microg/ml for 5 to 8 h and 1 microg/ml for 4 to 6 hours (T(1/2) ranges from 1.5-2 h). The following interpretive criteria were suggested: /= 15 mm (susceptible) and >/= 8 microg/ml or /= 18 mm (susceptible) and >/= 4 microg/ml or
机译:头孢托仑(以前为ME-1206)是一种经研究的口服头孢菌素酯,对许多革兰氏阳性和阴性菌具有杀菌活性。全国临床实验室标准委员会(NCCLS)参考肉汤微稀释法和标准化的圆盘扩散法确定了针对近1000种非提神物种的头孢托仑效价。针对葡萄球菌,就效力和药敏性解释(mec A阴性菌株)而言,可用的头孢托仑活性与奥沙西林完全相关。头孢托仑对克雷伯菌,奇异变形杆菌,沙门氏菌和大肠杆菌非常活跃(MIC(90)范围为0.12-1 microg / ml;中位区域为23-26 mm)。头孢托仑对柠檬酸杆菌,肠杆菌,粘质沙雷氏菌和吲哚阳性蛋白酶的活性更有限(MIC(50)范围,0.12-1 microg / ml; MIC(90),> 16 microg / ml;中位数, 18-25毫米)。针对铜绿假单胞菌,嗜麦芽窄食单胞菌,不动杆菌属和其他非发酵菌,头孢地汀没有活性(MIC(90),> 16 microg / ml;区域,6 mm)。头孢托仑的药代动力学分析表明,所用剂量产生的血浆浓度在5至8小时内超过0.5微克/毫升,在4至6小时内超过1微克/毫升(T(1/2)范围为1.5-2小时)。建议使用以下解释标准: / = 15 mm(易感)和> / = 8 microg / ml或 / = 18 mm(易感)和> / = 4 microg / ml或

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号